Attached files
file | filename |
---|---|
EX-23.1 - EXHIBIT 23.1 - Cerevel Therapeutics Holdings, Inc. | nt10009663x9_ex23-1.htm |
EX-5.2 - EXHIBIT 5.2 - Cerevel Therapeutics Holdings, Inc. | nt10009663x9_ex5-2.htm |
EX-5.1 - EXHIBIT 5.1 - Cerevel Therapeutics Holdings, Inc. | nt10009663x9_ex5-1.htm |
As filed with the United States Securities and Exchange Commission on June 4, 2020 under the Securities Act of 1933, as amended.
No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
ARYA Sciences Acquisition Corp II
(Exact name of registrants as specified in their charters)
Cayman Islands
(State or other jurisdiction of incorporation
or organization)
|
6770
(Primary Standard Industrial
Classification Code Number)
|
98-1533670
(I.R.S. Employer Identification Number)
|
51 Astor Place, 10th Floor
New York, New York 10003
(212) 248-2300
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Adam Stone
51 Astor Place, 10th Floor
New York, New York 10003
(212) 248-2300
(Name, address, including zip code, and telephone number, including area code, of agent for service).
Copies:
Christian O. Nagler
Ross Leff
Kirkland & Ellis LLP
601 Lexington Avenue
New York, New York 10022
Tel: (212) 446-4800
Fax: (212) 446-4900
|
Gregg A. Noel
Michael J. Mies
Skadden, Arps, Slate, Meagher & Flom LLP
525 University Avenue, Suite 1400
Palo Alto, California 94301
Tel: (650) 470-4500
Fax: (650) 470-4570
|
Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration
statement.
If the securities being registered on this form are being offered in connection with the formation of a holding company and there is compliance with General Instruction G,
check the following box. ☐
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the
following box: ☐
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. ☒ 333-238488
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth
company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐
|
Accelerated filer ☐
|
Non-accelerated filer ☒
|
Smaller reporting company ☒
|
Emerging growth company ☒
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
CALCULATION OF REGISTRATION FEE
Title of Each Class of Securities
Being Registered
|
Amount
Being
Registered(2)
|
Proposed
Maximum
Offering Price
Per Security(1)
|
Proposed
Maximum
Aggregate
Offering Price(1)
|
Amount of
Registration
Fee
|
|
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant
|
575,000 units
|
$10.00
|
$5,750,000
|
$747
|
|
Class A ordinary shares included as part of the units(3)
|
575,000 shares
|
—
|
—
|
— (4)
|
|
Redeemable warrants included as part of the units(3)
|
191,667 warrants
|
—
|
—
|
— (4)
|
|
Total
|
$5,750,000
|
$747(5)
|
|||
(1)
|
Estimated solely for the purpose of calculating the registration fee.
|
(2)
|
Represents only the additional number of securities being registered. Does not include the securities that the Registrant previously registered on the Registration Statement on Form
S-1 (File No. 333-238488).
|
(3)
|
Pursuant to Rule 416(a), there are also being registered an indeterminable number of additional securities as may be offered or issued to prevent dilution resulting from stock splits,
stock dividends, or similar transactions.
|
(4)
|
No fee pursuant to Rule 457(g).
|
(5)
|
The Registrant previously registered securities having a proposed maximum aggregate offering price of $143,750,000 on its Registration Statement on Form S-1, as amended (File No.
333-238488), which was declared effective by the Securities and Exchange Commission on June 4, 2020. In accordance with Rule 462(b) under the Securities Act, an additional number of securities having a proposed maximum offering price of
$5,750,000 is hereby registered, which includes securities issuable upon the exercise of the underwriters’ option to purchase additional units.
|
EXPLANATORY NOTE
This Registration Statement on Form S-1 is being filed with respect to the registration of 575,000 additional units of ARYA Sciences Acquisition Corp II, a Cayman Islands exempted company (the
“Registrant”), each consisting of one Class A ordinary share and one-third of one redeemable warrant, pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and General Instruction V to Form S-1. Each whole warrant entitles the holder
thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment, and only whole warrants are exercisable. This Registration Statement relates to the Registrant’s Registration Statement on Form S-1, as amended
(File No. 333-238488) (the “Prior Registration Statement”), initially filed by the Registrant on May 19, 2020 and declared effective by the Securities and Exchange Commission (the “Commission”) on June 4, 2020. The required opinions of counsel and
related consents and accountant’s consent are attached hereto and filed herewith. Pursuant to Rule 462(b), the contents of the Prior Registration Statement, including the exhibits thereto, are incorporated by reference into this Registration
Statement.
CERTIFICATION
The Registrant hereby certifies to the Commission that (1) it has instructed its bank to pay the filing fee set forth on the cover page of this Registration Statement by a wire transfer of such
amount to the Commission’s account at U.S. Bank as soon as practicable (but no later than the close of business as of June 5, 2020), (2) it will not revoke such instructions, (3) it has sufficient funds in the relevant account to cover the amount of
such filing fee and (4) it will confirm receipt of such instructions by its bank during regular business hours no later than June 5, 2020.
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 16. Exhibits and Financial Statement Schedules.
(a) Exhibits. All exhibits filed with or incorporated by reference in the Prior
Registration Statement on Form S-1 (SEC File No. 333-238488) are incorporated by reference into, and shall be deemed a part of, this Registration Statement, and the following additional exhibits are filed herewith, as part of this Registration
Statement:
Exhibit No.
|
Description
|
Opinion of Kirkland & Ellis LLP.
|
|
Opinion of Ogier, Cayman Islands Counsel to the Registrant.
|
|
Consent of WithumSmith+Brown, PC.
|
|
Consent of Kirkland & Ellis LLP (included on Exhibit 5.1).
|
|
Consent of Ogier (included on Exhibit 5.2).
|
|
Power of Attorney (included on signature page to the Registrant’s Prior Registration Statement (File No. 333-238488) filed on May 19, 2020).
|
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Registration Statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the city of New York, New York, on the 4th day of June 2020.
ARYA SCIENCES ACQUISITION CORP II
|
|
By: /s/ Adam Stone
|
|
Name: Adams Stone
|
|
Title: Chief Executive Officer
|
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed below by the following persons in the capacities and on
the dates indicated.
Name
|
Position
|
Date
|
/s/ Joseph Edelman
|
||
Joseph Edelman
|
Chairman
|
June 4, 2020
|
/s/ Adam Stone
|
Chief Executive Officer and Director
(Principal Executive Officer)
|
June 4, 2020
|
Adam Stone
|
||
/s/Michael Altman
|
Chief Financial Officer and Director
(Principal Financial and Accounting Officer)
|
June 4, 2020
|
Michael Altman
|
||
/s/ Jake Bauer
|
||
Jake Bauer
|
Director
|
June 4, 2020
|
/s/ Chad Robins
|
||
Chad Robins
|
Director
|
June 4, 2020
|
/s/ Todd Wider
|
||
Todd Wider
|
Director |
June 4, 2020
|